Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ARTV
$6.20
-4.47%
ARTV
· Artiva Biotherapeutics, Inc.
$6.20
-0.29 (-4.47%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$307.52M
Shares
48.89M
Volume · Oct 22
393.91K
Avg daily vol (3M)
407.57K
All webcasts
Earnings call · FY2026 Q1
Artiva Biotherapeutics, Inc. (ARTV) Q1 2026 Earnings Call
Diluted EPS
-$0.95
Net income
-$23.52M
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed May 8, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Targeted ACR50 at 6 months for AlloNK+RTX
at 6 months
|
at least 50% | — | |
|
Targeted ACR50 at 6 months for RTX-only
at 6 months
|
20% – 25% | — |
SEC filing · Item 2.02
8-K earnings release
Filed May 8, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 8, 2026 · complete as-filed document